Issue 3/2016
Content (10 Articles)
Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?
Livio Garattini, Anna Padula, Milene Rangel Da Costa
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community
Bernhard Ultsch, Oliver Damm, Philippe Beutels, Joke Bilcke, Bernd Brüggenjürgen, Andreas Gerber-Grote, Wolfgang Greiner, Germaine Hanquet, Raymond Hutubessy, Mark Jit, Mirjam Knol, Rüdiger von Kries, Alexander Kuhlmann, Daniel Levy-Bruhl, Matthias Perleth, Maarten Postma, Heini Salo, Uwe Siebert, Jürgen Wasem, Ole Wichmann
Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Munira Essat, Paul Tappenden, Shijie Ren, Alice Bessey, Rachel Archer, Ruth Wong, Alan Lobo, Sami Hoque
Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges
Jordana K. Schmier, Carolyn K. Hulme-Lowe
Are Efficient Designs Used in Discrete Choice Experiments Too Difficult for Some Respondents? A Case Study Eliciting Preferences for End-of-Life Care
Terry N. Flynn, Marcel Bilger, Chetna Malhotra, Eric A. Finkelstein
Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation
Monika Wagner, Hanane Khoury, Jacob Willet, Donna Rindress, Mireille Goetghebeur
Budget Impact Analysis of Using Dihydroartemisinin–Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania
Amani Thomas Mori, Ole Frithjof Norheim, Bjarne Robberstad
Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives
Jill Bindels, Bram Ramaekers, Isaac Corro Ramos, Leyla Mohseninejad, Saskia Knies, Janneke Grutters, Maarten Postma, Maiwenn Al, Talitha Feenstra, Manuela Joore